dihydrokainate has been researched along with ascorbic acid in 1 studies
Studies (dihydrokainate) | Trials (dihydrokainate) | Recent Studies (post-2010) (dihydrokainate) | Studies (ascorbic acid) | Trials (ascorbic acid) | Recent Studies (post-2010) (ascorbic acid) |
---|---|---|---|---|---|
180 | 0 | 46 | 45,261 | 2,497 | 11,176 |
Protein | Taxonomy | dihydrokainate (IC50) | ascorbic acid (IC50) |
---|---|---|---|
Chain A, Hyaluronidase, phage associated | Streptococcus pyogenes | 1000 | |
Urease | Canavalia ensiformis (jack bean) | 8.59 | |
Solute carrier family 23 member 1 | Homo sapiens (human) | 156 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barton, SJ; Bunner, KD; Dorner, JL; Gaither, TW; Klein, EL; Miller, BR; Rebec, GV | 1 |
1 other study(ies) available for dihydrokainate and ascorbic acid
Article | Year |
---|---|
Up-regulation of GLT1 reverses the deficit in cortically evoked striatal ascorbate efflux in the R6/2 mouse model of Huntington's disease.
Topics: Animals; Ascorbic Acid; Ascorbic Acid Deficiency; Aspartic Acid; Ceftriaxone; Cerebral Cortex; Corpus Striatum; Electric Stimulation; Excitatory Amino Acid Transporter 2; Extracellular Fluid; Genotype; Huntington Disease; Kainic Acid; Male; Mice; Mice, Transgenic; Microinjections; Transcription, Genetic; Up-Regulation | 2012 |